glp 1 drugs for parkinson's disease Are we measuring the wrong primary outcome GLP-1 for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep The most extensive research to-date
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



01022-6/asset/3f55ea20-b36b-4e11-88e9-940a60e8677e/main.assets/gr2_lrg.jpg)




00125-7/asset/85fa7e17-4785-4f71-9b61-806d7ecb7b4a/main.assets/gr2_lrg.jpg)













